IL-6 (100 ng/mL) stimulated levels of pSTAT3 at baseline and 2 hours after administration of 25 mg of ruxolitinib. Cells stimulated and providing the signal are monocytes and AML blasts. Patients marked with an asterisk were positive for the presence of JAK2V617F.